These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38508322)

  • 1. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials.
    Zhou Y; Wang T; He H; Li Q; Wan Z; Lu P; Shu C
    Int J Cardiol; 2024 Jun; 404():131977. PubMed ID: 38508322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
    Zhou Y; Wang J; He H; Li Q; Li M; Li X; Shu C
    Int J Cardiol; 2021 Nov; 343():122-130. PubMed ID: 34461162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
    J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-Analysis Comparing Endovascular Treatment Modalities for Femoropopliteal Peripheral Artery Disease.
    Khan MS; Zou F; Khan AR; Moustafa A; Schmid CH; Baig M; Hyder ON; Aronow HD
    Am J Cardiol; 2020 Aug; 128():181-188. PubMed ID: 32650917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.
    Koeckerling D; Raguindin PF; Kastrati L; Bernhard S; Barker J; Quiroga Centeno AC; Raeisi-Dehkordi H; Khatami F; Niehot C; Lejay A; Szeberin Z; Behrendt CA; Nordanstig J; Muka T; Baumgartner I
    Eur Heart J; 2023 Mar; 44(11):935-950. PubMed ID: 36721954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
    Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-level and external factors in the use of drug-coated balloons and drug-eluting stents in femoropopliteal endovascular interventions.
    Castro-Dominguez Y; Smolderen KG; Pichert M; Alabi O; Romain G; Huang J; Lee M; Ahmed Z; Peri-Okonny PA; Arham A; Brice A; Chaar CO; Stacy MR; Mena-Hurtado C
    J Vasc Surg; 2022 Dec; 76(6):1675-1680. PubMed ID: 35868423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis Prevention With Drug Eluting or Covered Stents in Femoropopliteal Arterial Occlusive Disease: Evidence From a Comprehensive Network Meta-analysis.
    He R; Ye Y; Li Z; Jiang Y; Li Y; Liu Y; Wang K; Yao C
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):61-74. PubMed ID: 31202582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy and Safety of Endovascular Treatment Modalities for Femoropopliteal Artery Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):204-214. PubMed ID: 31646376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Network Meta-analysis of Randomized Controlled Trials Comparing Treatment Modalities for Infrapopliteal Lesions in Critical Limb Ischemia.
    Zhou Y; Lin S; Zhang Z; Xiao J; Ai W; Wang J; Li Y; Li Q
    Ann Vasc Surg; 2019 Oct; 60():424-434. PubMed ID: 31075473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
    Bausback Y; Wittig T; Schmidt A; Zeller T; Bosiers M; Peeters P; Brucks S; Lottes AE; Scheinert D; Steiner S
    J Am Coll Cardiol; 2019 Feb; 73(6):667-679. PubMed ID: 30765033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
    Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
    [No Abstract]   [Full Text] [Related]  

  • 15. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
    Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
    J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the impact of the loss of patency between treatment with drug-coated balloon angioplasty and drug-eluting stent placement.
    Nagatomi S; Takahara M; Nakai T; Fujimura N; Yu A; Matsuda D; Yamaoka T; Bolstad F; Yamamoto H; Ichihashi S
    J Vasc Surg; 2023 Jun; 77(6):1751-1759. PubMed ID: 36796593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
    Zenunaj G; Traina L; Acciarri P; Mario Cosacco A; Alesiani F; Baldazzi G; Gasbarro V
    Ann Vasc Surg; 2023 May; 92():294-303. PubMed ID: 36746268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
    Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
    J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.